bourva
OMX · CPH Materials NZYM-B

Novonesis (Novozymes) share price

NZYM-B · Novonesis (Novozymes)
DKK 380.00 ▼ DKK 0.14 · -0.04%
Market open · 15:26 local Jun 26, 2026 Prices delayed ≥15 min Sample data

Price chart

Key statistics

Market cap
DKK 171.00B
P/E (TTM)
35.0×
EPS (TTM)
DKK 10.86
Dividend yield
2.09%
52-week range
DKK 292.00 – DKK 422.61
Avg volume
1.2M
Beta
1.11
Prev close
DKK 380.14

About Novonesis (Novozymes)

AI-assisted summary

Novonesis (Novozymes) (NZYM-B) is a company listed on OMX in the Materials sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.

Dividend history

Annual payout (TTM): DKK 7.94 · Forward yield: 2.09%
Ex-date Pay date Amount Frequency Dividend yield
Jun 21, 2026 Jun 28, 2026 DKK 7.94 Annual 2.09%
Jun 21, 2025 Jun 28, 2025 DKK 6.20 Annual 1.63%
Jun 21, 2024 Jun 28, 2024 DKK 7.85 Annual 2.07%

Financials

Annual figures, last 5 fiscal years.

Date Revenue Net income EPS (TTM) P/E (TTM)
FY2024 DKK 64.69B DKK 11.35B DKK 7.95 35.9×
FY2023 DKK 54.57B DKK 3.77B DKK 9.27 45.2×
FY2022 DKK 47.27B DKK 10.37B DKK 10.12 29.1×
FY2021 DKK 39.77B DKK 4.73B DKK 10.98 41.9×
FY2020 DKK 35.58B DKK 3.48B DKK 12.01 35.3×

Stock splits

No stock splits on record for Novonesis (Novozymes).

Analyst forecast

12-month price target
DKK 470.26
Consensus rating
Strong buy
Implied upside
+23.75%
Based on 6 analysts
12-month

Aggregated analyst estimates (sample)

Related

Frequently asked questions

What is the current Novonesis (Novozymes) share price?

Novonesis (Novozymes) (NZYM-B) last traded at DKK 380.00, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.

Does Novonesis (Novozymes) pay a dividend?

Yes — Novonesis (Novozymes) has a forward dividend yield of about 2.09%, based on its trailing 12-month payout.

What is Novonesis (Novozymes)'s market capitalisation?

Novonesis (Novozymes) has an approximate market capitalisation of DKK 171.00B.

What is Novonesis (Novozymes)'s P/E ratio?

Novonesis (Novozymes) trades at a trailing P/E ratio of about 35.0.

Compare with another ticker
See two tickers side by side — price, valuation and dividends.